External Physical Vibration Lithecbole(EPVL) Versus Traditional Treatment for 4-10 mm Ureteral Stone

Sponsor
Guohua Zeng (Other)
Overall Status
Unknown status
CT.gov ID
NCT03730389
Collaborator
(none)
208
1
2
27
7.7

Study Details

Study Description

Brief Summary

The investigator aims to perform a prospective and randomized controlled trial evaluating the safety and efficacy of External Physical Vibration Lithecbole(EPVL) in treating 4-10 mm ureteral stone.

Condition or Disease Intervention/Treatment Phase
  • Device: External Physical Vibration Lithecbole (EPVL)
N/A

Detailed Description

Patients with ureteral stones less than 10 mm, would receive observation for stone passage, not requiring immediate surgery. There are many studies evaluating the effect of Medical expulsive therapy in treating ureteral stones, including a-blockers, and calcium channel blockers. Most of shuties concluded that the benefit of a-blockers might be among those with larger (distal) stones. There is no good method for the removal of upper ureteral calculi, except drinking water and exercising.

Recently, a new extracorporeal physical vibrational lithecbole (EPVL) device named Friend-I EPVL (Zhengzhou Fu Jian Da Medical Instrument Co., Zhengzhou, China) has proven to be an effective treatment for upper urinary tract residual calculi. The device was approved by the Chinese food and drug administration in 2012. A Simple harmonic motion technology in multi-direction was applied. The Lateral acceleration was provided by the physical vibration device in the base through the harmonic vibration wave in the horizontal direction, which induces the urinary stone separate with the kidney or ureter, and expands a moving space for the stone. Meanwhile, an axial effect was produced to push the stone by the physical vibration device in the handle through the harmonic vibration wave in the multi- direction. So, we think that EPVL may be effective in treating ureteral stones.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
208 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
External Physical Vibration Lithecbole(EPVL) for ureteral stoneExternal Physical Vibration Lithecbole(EPVL) for ureteral stone
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
External Physical Vibration Lithecbole(EPVL) Versus Traditional Treatment for 4-10 mm Ureteral Stone: A Multi-center Prospective Randomized Controlled Trial
Actual Study Start Date :
Aug 1, 2018
Anticipated Primary Completion Date :
Aug 1, 2020
Anticipated Study Completion Date :
Nov 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: EPVL Group

In treatment group, patients were given one to three sessions of External Physical Vibration Lithecbole therapy in two weeks. These patients were also instructed to drink a minimum of 2500 ml water daily and take more exercise.

Device: External Physical Vibration Lithecbole (EPVL)
Using the the way of external physical vibration to promote separation of stones from ureteral mucosa and promoting the excretion of ureteral stones

No Intervention: Traditional Group

patients with 4-10mm ureteral stone, were treated by traditional treatment methods, including drinking a minimum of 2500 ml water daily and taking more exercise.

Outcome Measures

Primary Outcome Measures

  1. Number of Participants With Stone Expulsion [14 days]

    The stone discharge rate of the two group

Secondary Outcome Measures

  1. Time to Stone Passage [14 days]

    Time to stone elimination in days in patients with spontaneous elimination

  2. The rate of renal colic [14 days]

    the mean rate of renal colic between the two groups

  3. Required Analgesics [14 days]

    the need for slow-released diclofenac tablet

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Adults age 18 to 70 years

  2. 4-10 mm single ureteral calculi

  3. Normal serum creatinine

  4. ASA grading: 1-2 levels.

Exclusion Criteria:
  1. Pregnant or isolated kidney patients

  2. Moderate or severe hydronephrosis

  3. History of ureteral stricture

  4. Multiple ureteral stones;

  5. Acute urinary tract infection

  6. Those who are taking α-receptor, calcium channel blocker or chinese medicine stone shovel

  7. Dysfunction of blood coagulation

  8. Obese patients (body mass index > 28 kg / m2);

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University Guangzhou Guangdong China 510230

Sponsors and Collaborators

  • Guohua Zeng

Investigators

  • Principal Investigator: Guohua Zeng, PH.D & MD, The First Affiliated Hospital of Guangzhou Medical University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Guohua Zeng, Vice president, The First Affiliated Hospital of Guangzhou Medical University
ClinicalTrials.gov Identifier:
NCT03730389
Other Study ID Numbers:
  • EPVL for 4-10mm ureteral stone
First Posted:
Nov 5, 2018
Last Update Posted:
Nov 5, 2018
Last Verified:
Nov 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Guohua Zeng, Vice president, The First Affiliated Hospital of Guangzhou Medical University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 5, 2018